N-tert-butyl-2-[4-(hydroxymethyl)phenyl]benzenesulfonamide | 263245-39-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-tert-butyl-2-[4-(hydroxymethyl)phenyl]benzenesulfonamide
• CAS: 263245-39-2
• 化学式: C₁₇H₂₁NO₃S
• 分子量: 319.425
• InChiKey: HQZFAFVSMFXRAE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  22
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  74.8
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  N-tert-butyl-2-[4-(hydroxymethyl)phenyl]benzenesulfonamide 在 四溴化碳 、 双硫磷 作用下， 生成 4'-(bromomethyl)-N-tert-butyl-2-biphenylsulfonamide
  参考文献：
  名称：

  New class of biphenylene dibenzazocinones as potent ligands for the human EP1 prostanoid receptor

  摘要：

  A new class of potent and selective ligands for the human EPI prostanoid receptor is described. SAR studies reported herein allowed the identification of several potent dibenzazocinones bearing an acylsulfonamide side chain. The binding affinity of these compounds on all eight human prostanoid receptors is reported. (C) 1999 Published by Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(99)00465-5
• 作为产物：
  描述：

  4-羟甲基苯硼酸 、 2-溴-N-叔丁基苯磺酰胺 生成 N-tert-butyl-2-[4-(hydroxymethyl)phenyl]benzenesulfonamide
  参考文献：
  名称：

  New class of biphenylene dibenzazocinones as potent ligands for the human EP1 prostanoid receptor

  摘要：

  A new class of potent and selective ligands for the human EPI prostanoid receptor is described. SAR studies reported herein allowed the identification of several potent dibenzazocinones bearing an acylsulfonamide side chain. The binding affinity of these compounds on all eight human prostanoid receptors is reported. (C) 1999 Published by Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(99)00465-5

文献信息

• Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors
  申请人：——

  公开号：US20020091104A1

  公开（公告）日：2002-07-11

  The invention encompasses the novel class of compounds represented by the formula below, which are inhibitors of the PTP-1B enzyme. 1 The invention also encompasses pharmaceutical compositions and methods of treating or preventing PTP-1B mediated diseases, including diabetes.

  本发明包括下式所代表的一类新型化合物，它们是 PTP-1B 酶的抑制剂。 1 本发明还包括治疗或预防 PTP-1B 介导的疾病（包括糖尿病）的药物组合物和方法。
• SULFUR SUBSTITUTED ARYLDIFLUOROMETHYLPHOSPHONIC ACIDS AS PTP-1B INHIBITORS
  申请人：Merck Frosst Canada & Co.

  公开号：EP1268494A1

  公开（公告）日：2003-01-02
• US6498151B2
  申请人：——

  公开号：US6498151B2

  公开（公告）日：2002-12-24
• [EN] SULFUR SUBSTITUTED ARYLDIFLUOROMETHYLPHOSPHONIC ACIDS AS PTP-1B INHIBITORS<br/>[FR] ACIDES ARYLDIFLUOROMETHYL PHOSPHONIQUES SUBSTITUES SOUFRE EN TANT QU'INHIBITEURS DE AS PTP-1B
  申请人：MERCK FROSST CANADA INC

  公开号：WO2001070753A1

  公开（公告）日：2001-09-27

  The invention encompasses the novel class of compounds represented by formula (I), which are inhibitors of the PTP-1B enzyme . The invention also encompasses pharmaceutical compositions and methods of treating or preventing PTP-1B mediated diseases, including diabetes.
• New class of biphenylene dibenzazocinones as potent ligands for the human EP1 prostanoid receptor
  作者：Réjean Ruel、Patrick Lacombe、Mark Abramovitz、Claude Godbout、Sonia Lamontagne、Chantal Rochette、Nicole Sawyer、Rino Stocco、Nathalie M. Tremblay、Kathleen M. Metters、Marc Labelle

  DOI：10.1016/s0960-894x(99)00465-5

  日期：1999.9

  A new class of potent and selective ligands for the human EPI prostanoid receptor is described. SAR studies reported herein allowed the identification of several potent dibenzazocinones bearing an acylsulfonamide side chain. The binding affinity of these compounds on all eight human prostanoid receptors is reported. (C) 1999 Published by Elsevier Science Ltd. All rights reserved.